Terms: = Head and neck cancer AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Staging
6 results:
1. mdm2 gene amplification in esophageal carcinoma.
Michalk M; Meinrath J; Künstlinger H; Koitzsch U; Drebber U; Merkelbach-Bruse S; Bollschweiler E; Kloth M; Hartmann W; Hölscher A; Quaas A; Grimminger PP; Odenthal M
Oncol Rep; 2016 Apr; 35(4):2223-7. PubMed ID: 26796597
[TBL] [Abstract] [Full Text] [Related]
2. A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.
Findlay JM; Middleton MR; Tomlinson I
Ann Oncol; 2015 Apr; 26(4):624-644. PubMed ID: 25214541
[TBL] [Abstract] [Full Text] [Related]
3. Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent.
Osman I; Sherman E; Singh B; Venkatraman E; Zelefsky M; Bosl G; Scher H; Shah J; Shaha A; Kraus D; Cordon-Cardo C; Pfister DG
J Clin Oncol; 2002 Jul; 20(13):2980-7. PubMed ID: 12089228
[TBL] [Abstract] [Full Text] [Related]
4. mdm2 expression in areca quid chewing-associated oral squamous cell carcinomas in Taiwan.
Huang JS; Ho TJ; Chiang CP; Kok SH; Kuo YS; Kuo MY
J Oral Pathol Med; 2001 Jan; 30(1):53-8. PubMed ID: 11140901
[TBL] [Abstract] [Full Text] [Related]
5. Expression of p21/waf1 in oral squamous cell carcinomas--correlation with p53 and mdm2 and cellular proliferation index.
Ng IO; Lam KY; Ng M; Regezi JA
Oral Oncol; 1999 Jan; 35(1):63-9. PubMed ID: 10211312
[TBL] [Abstract] [Full Text] [Related]
6. The influence of p53 and associated factors on the outcome of patients with oral squamous cell carcinoma.
Stoll C; Baretton G; Löhrs U
Virchows Arch; 1998 Nov; 433(5):427-33. PubMed ID: 9849857
[TBL] [Abstract] [Full Text] [Related]